These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 3373685)

  • 1. Vasodilator therapy for heart failure: what have we learned from controlled clinical trials?
    Cohn JN; Rector TS
    JAMA; 1988 Jun; 259(23):3456-7. PubMed ID: 3373685
    [No Abstract]   [Full Text] [Related]  

  • 2. Vasodilator therapy for congestive heart failure. Lessons from mortality trials.
    Groden DL
    Arch Intern Med; 1993 Feb; 153(4):445-54. PubMed ID: 8435024
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vasodilator therapy in heart failure.
    Kubo SH
    J Heart Lung Transplant; 1994; 13(4):S122-5. PubMed ID: 7947868
    [No Abstract]   [Full Text] [Related]  

  • 4. Flosequinan for heart failure.
    Med Lett Drugs Ther; 1993 Mar; 35(892):23-4. PubMed ID: 8441362
    [No Abstract]   [Full Text] [Related]  

  • 5. Modern management of heart failure.
    Davies MK
    Br J Hosp Med; 1992 Jan 9-22; 47(1):16-8, 20-2, 24. PubMed ID: 1737187
    [TBL] [Abstract][Full Text] [Related]  

  • 6. What have we learned from clinical trials in congestive heart failure?
    Swedberg K
    J Intern Med; 1996 Apr; 239(4):307-8. PubMed ID: 8774384
    [No Abstract]   [Full Text] [Related]  

  • 7. [Drug treatment of congestive heart failure: from large trials to clinical application].
    Guazzi MD
    Cardiologia; 1994 Mar; 39(3):157-8. PubMed ID: 8039193
    [No Abstract]   [Full Text] [Related]  

  • 8. Relative efficacy of vasodilator therapy in chronic congestive heart failure. Implications of randomized trials.
    Mulrow CD; Mulrow JP; Linn WD; Aguilar C; Ramirez G
    JAMA; 1988 Jun; 259(23):3422-6. PubMed ID: 3286914
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of vasodilator therapy in congestive heart failure. Effects on mortality.
    Greenberg B
    Cardiol Clin; 1994 Feb; 12(1):87-99. PubMed ID: 8181028
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Using exercise endpoints in heart failure trials: design considerations.
    Yusuf S; Tsuyuki R
    Eur Heart J; 1996 Jan; 17(1):4-6. PubMed ID: 8682129
    [No Abstract]   [Full Text] [Related]  

  • 11. [Two sides of the coin, or converting enzyme inhibitors in the therapy of heart failure].
    Guazzi MD; Berti M; Dardani M; Muratori E; Guazzi M
    Cardiologia; 1989 Jan; 34(1):15-8. PubMed ID: 2655899
    [No Abstract]   [Full Text] [Related]  

  • 12. Effects of vasodilator therapy on survival in patients with chronic heart failure.
    Jafri SM; Gheorghiade M; Levine TB; Goldstein S
    Prog Cardiovasc Dis; 1992; 35(3):213-8. PubMed ID: 1438791
    [No Abstract]   [Full Text] [Related]  

  • 13. ACE inhibitors in early stages of heart failure.
    Riegger GA
    Circulation; 1993 May; 87(5 Suppl):IV117-9. PubMed ID: 8485826
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Heart failure trials.
    Clark A; Coats A
    Br J Hosp Med; 1996 Jun 19-Jul 9; 56(1):29-31. PubMed ID: 8831010
    [No Abstract]   [Full Text] [Related]  

  • 15. The current role of digoxin in the treatment of heart failure.
    Smith JR; Gheorghiade M; Goldstein S
    Coron Artery Dis; 1993 Jan; 4(1):16-26. PubMed ID: 8269181
    [No Abstract]   [Full Text] [Related]  

  • 16. [Vasodilator agents in chronic heart failure: which is the best option?].
    Corbalán R; Kunstmann S; Jalil J
    Rev Med Chil; 1993 Jan; 121(1):81-8. PubMed ID: 8235172
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Exercise test in the evaluation of the efficacy of drug therapy].
    Febo O; Cobelli F
    Ital Heart J Suppl; 2000 Mar; 1(3):393-9. PubMed ID: 10815269
    [No Abstract]   [Full Text] [Related]  

  • 18. Digitalis and non-ACE inhibitor vasodilators in heart failure.
    Chatterjee K
    Cardiol Clin; 1989 Feb; 7(1):99-118. PubMed ID: 2650876
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapy for congestive heart failure in the late 20th century.
    Maxwell LP; Jain A
    W V Med J; 1993 Apr; 89(4):148-51. PubMed ID: 8098171
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The evolving role of angiotensin-converting enzyme inhibition in heart failure: expanding the protective envelope.
    Teerlink JR
    J Cardiovasc Pharmacol; 1994; 24 Suppl 3():S32-7. PubMed ID: 7700062
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.